Back to Agenda
Session 1B: Pharmacovigilance in India
Session Chair(s)
Ajoy Roy
Senior Medical Director and Head Medical Affairs
PAREXEL, India
This session will describe the status of pharma- covigilance regulation and practices in India, with a focus on monitoring the safe use of markets drugs and ways to take prompt remedial action when and if necessary.
Speaker(s)
Postmarketing Pharmacovigilance Regulations and Practices in India
Y K Gupta
AIIMS, India
Former Dean
Mangesh Kulkarni, MD
Tata Consultancy Services, India
Global Drug Safety - Physician and Head of Practice
Have an account?